Company Data
Cognition Therapeutics Inc.
Ticker
CGTX
Current Price
$0.3238 -0.22%
Market Cap
$20.1M
Price Target
Refer to Report
Volume
356.3K
52wk Range
$0.222301 - $2.535
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.